ALPMY 財務： Astellas Pharma Inc. AI 分析



財務狀況

ALPMY 財務

Astellas Pharma Inc.

$14.16

5.43%

$0.73

收盤價：May 29, 16:00:00 GMT-4

$14.16

盤後：May 29, 20:00:00 GMT-4

概觀預測收益股利財務狀況

關鍵數據

前收市價

$13.43

開盤價

$14.21

當日範圍

$14 - $14.24

52週區間

$9.11 - $17.35

交易量

9.8K

平均成交量

155.2K

股息收益率

每股盈餘 (TTM)

1.03

市值

$25.3B

什麼是 Astellas Pharma, Inc.？

安斯泰來製藥股份有限公司從事藥品的研發、製造、進口和出口業務。公司總部位於東京都中央區，目前僱用13,643名全職員工。公司主要營運藥品業務部門。主要產品包括XTANDI、BETANIS、MIRABETRIC、BETMIGA以及新產品ZOSPATA、EVERENZO和ENHOLTUMAB VEDOTIN等。

功能特性

Markets

News

使用條款隱私權政策

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
營收	2,139,245	537,925	571,206	524,320	505,794	459,294
營收年增率 (YoY)	12%	17%	10%	13%	7%	11%
營收成本	408,426	93,667	114,400	105,530	94,829	76,858
毛利	1,730,819	444,258	456,806	418,790	410,965	382,436
銷售、一般及管理費用	860,312	234,699	221,779	206,837	196,997	211,316
研發	314,827	95,943	75,595	71,591	71,698	76,229
營業費用	1,350,760	395,690	322,264	314,382	318,424	319,334
其他非營業收入 (費用)	--	--	--	--	--	1
稅前淨利	376,587	48,024	133,957	104,189	90,417	60,554
所得稅費用	85,013	4,408	33,634	24,977	21,994	-14,342
淨利	291,535	43,521	100,379	79,213	68,422	74,896
淨利成長	474%	-42%	-202.99%	121%	82%	-325%
稀釋後流通股數	1,791.48	1,791.48	1,791.31	1,791.2	1,795.38	1,818.02
股數年變動 (YoY)	-1%	-1%	0%	0%	0%	1%
每股盈餘 (稀釋)	162.73	24.29	56.03	44.22	38.11	41.19
每股盈餘成長率	483%	-41%	-202.99%	121%	82%	-322%
自由現金流	475,543	184,536	57,375	194,583	39,049	89,198
每股自由現金流	--	--	--	--	--	--
毛利率	80.9%	82.58%	79.97%	79.87%	81.25%	83.26%
營業利益率	17.76%	9.02%	23.55%	19.91%	18.29%	13.73%
淨利率	13.62%	8.09%	17.57%	15.1%	13.52%	16.3%
自由現金流利潤率	22.22%	34.3%	10.04%	37.11%	7.72%	19.42%
EBITDA	516,041	84,332	169,271	137,130	125,308	95,663
EBITDA 利潤率	24.12%	15.67%	29.63%	26.15%	24.77%	20.82%
EBITDA 中的折舊與攤銷	135,982	35,764	34,729	32,722	32,767	32,561
EBIT	380,059	48,568	134,542	104,408	92,541	63,102
EBIT 利潤率	17.76%	9.02%	23.55%	19.91%	18.29%	13.73%
有效稅率	22.57%	9.17%	25.1%	23.97%	24.32%	-23.68%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

營收

2,139,245

537,925

571,206

524,320

505,794

459,294

營收年增率 (YoY)

12%

17%

10%

13%

11%

營收成本

408,426

93,667

114,400

105,530

94,829

76,858

毛利

1,730,819

444,258

456,806

418,790

410,965

382,436

銷售、一般及管理費用

860,312

234,699

221,779

206,837

196,997

211,316

研發

314,827

95,943

75,595

71,591

71,698

76,229

營業費用

1,350,760

395,690

322,264

314,382

318,424

319,334

其他非營業收入 (費用)

稅前淨利

376,587

48,024

133,957

104,189

90,417

60,554

所得稅費用

85,013

4,408

33,634

24,977

21,994

-14,342

淨利

291,535

43,521

100,379

79,213

68,422

74,896

淨利成長

474%

-42%

-202.99%

121%

82%

-325%

稀釋後流通股數

1,791.48

1,791.31

1,791.2

1,795.38

1,818.02

股數年變動 (YoY)

-1%

每股盈餘 (稀釋)

162.73

24.29

56.03

44.22

38.11

41.19

每股盈餘成長率

483%

-41%

-202.99%

121%

82%

-322%

自由現金流

475,543

184,536

57,375

194,583

39,049

89,198

每股自由現金流

毛利率

80.9%

82.58%

79.97%

79.87%

81.25%

83.26%

營業利益率

17.76%

9.02%

23.55%

19.91%

18.29%

13.73%

淨利率

13.62%

8.09%

17.57%

15.1%

13.52%

16.3%

自由現金流利潤率

22.22%

34.3%

10.04%

37.11%

7.72%

19.42%

EBITDA

516,041

84,332

169,271

137,130

125,308

95,663

EBITDA 利潤率

24.12%

15.67%

29.63%

26.15%

24.77%

20.82%

EBITDA 中的折舊與攤銷

135,982

35,764

34,729

32,722

32,767

32,561

EBIT

380,059

48,568

134,542

104,408

92,541

63,102

EBIT 利潤率

17.76%

9.02%

23.55%

19.91%

18.29%

13.73%

有效稅率

22.57%

9.17%

25.1%

23.97%

24.32%

-23.68%

Follow-Up Questions

What are Astellas Pharma Inc.'s key financial statements?



According to the latest financial statement (Form-10K), Astellas Pharma Inc. has a total asset of $0, Net 損失 of $0

What are the key financial ratios for ALPMY?



Astellas Pharma Inc.'s Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Astellas Pharma Inc.'s revenue broken down by segment or geography?



Astellas Pharma Inc. 最大收入來源為 Pharmaceutical，在最近的收益報告中收入為 1,912,323,000,000。就地區而言，United States 是 Astellas Pharma Inc. 的主要市場，收入為 866,378,000,000。

Is Astellas Pharma Inc. profitable?



無, according to the latest financial statements, Astellas Pharma Inc. has a net 損失 of $0

Does Astellas Pharma Inc. have any liabilities?



無, Astellas Pharma Inc. has liability of 0

How many outstanding shares for Astellas Pharma Inc.?



Astellas Pharma Inc. has a total outstanding shares of 0

Astellas Pharma Inc. (ALPMY) 財務

ALPMY 股價走勢圖

關鍵數據

前收市價

開盤價

當日範圍

52週區間

交易量

平均成交量

股息收益率

每股盈餘 (TTM)

市值

什麼是 Astellas Pharma, Inc.？

Astellas Pharma Inc. (ALPMY) 財務

ALPMY 股價走勢圖

關鍵數據

前收市價

開盤價

當日範圍

52週區間

交易量

平均成交量

股息收益率

每股盈餘 (TTM)

市值

什麼是 Astellas Pharma, Inc.？

ALPMY 收入

Follow-Up Questions

What are Astellas Pharma Inc.'s key financial statements?

What are the key financial ratios for ALPMY?

How is Astellas Pharma Inc.'s revenue broken down by segment or geography?

Is Astellas Pharma Inc. profitable?

Does Astellas Pharma Inc. have any liabilities?

How many outstanding shares for Astellas Pharma Inc.?